Advertisement
Original articles| Volume 56, ISSUE 9, P657-664, November 01, 2004

Download started.

Ok

High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation

      Background

      A wide variety of antidepressants act as noncompetitive antagonists of nicotinic acetylcholine receptors (nAChRs), but the relationship between this antagonism and the therapeutic effects of antidepressants is unknown.

      Methods

      Antidepressant properties of the noncompetitive nAChR antagonist mecamylamine in the forced swim test were tested alone and in combination with the tricyclic antidepressant amitriptyline. Mice lacking high-affinity nAChRs were tested in three behavioral models to determine whether these receptors are required for behavioral effects of amitriptyline in common models of antidepressant action. Finally, the brains of wild-type and knockout animals treated with amitriptyline were examined to determine whether high-affinity nAChRs are required for antidepressant-induced increases in hippocampal cell proliferation.

      Results

      Inhibition of nAChRs by mecamylamine had antidepressant-like effects in the forced swim test and potentiated the antidepressant activity of amitriptyline when the two drugs were used in combination. Mice lacking high-affinity nAChRs showed no behavioral response to amitriptyline. Finally, after chronic treatment with amitriptyline, nAChR knockout mice did not show the increase in hippocampal cell proliferation seen in wild-type mice.

      Conclusions

      These data support the hypothesis that antagonism of nAChRs is an essential component of the therapeutic action of antidepressants.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Alonso R.
        • Griebel G.
        • Pavone G.
        • Stemmelin J.
        • Le Fur G.
        • Soubrie P.
        Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression.
        Mol Psychiatry. 2003; 9 (224): 278-286
        • Belluardo N.
        • Blum M.
        • Mudo G.
        • Andbjer B.
        • Fuxe K.
        Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat.
        Neuroscience. 1998; 83: 723-740
        • Caldarone B.J.
        • George T.P.
        • Zachariou V.
        • Picciotto M.R.
        Gender differences in learned helplessness behavior are influenced by genetic background.
        Pharmacol Biochem Behav. 2000; 66: 811-817
        • Caldarone B.J.
        • Karthigeyan K.
        • Harrist A.
        • Hunsberger J.G.
        • Wittmack E.
        • King S.L.
        • et al.
        Sex differences in response to oral amitriptyline in three animal models of depression in C57BL/6J mice.
        Psychopharmacology. 2003; 170: 94-9101
        • Crawley J.N.
        • Belknap J.K.
        • Collins A.
        • Crabbe J.C.
        • Frankel W.
        • Henderson N.
        • et al.
        Behavioral phenotypes of inbred mouse strains.
        Psychopharmacology. 1997; 132: 107-124
        • Dilsaver S.C.
        Cholinergic mechanisms in depression.
        Brain Res. 1986; 396: 285-316
        • Dilsaver S.C.
        • Alessi N.E.
        Chronic inescapable footshock produces cholinergic system supersensitivity.
        Biol Psychiatry. 1987; 22: 914-918
        • Dilsaver S.C.
        • Snider R.M.
        • Alessi N.E.
        Stress induces supersensitivity of a cholinergic system in rats.
        Biol Psychiatry. 1986; 21: 1093-1096
        • Djuric V.J.
        • Dunn E.
        • Overstreet D.H.
        • Dragomir A.
        • Steiner M.
        Antidepressant effect of ingested nicotine in female rats of Flinders resistant and sensitive lines.
        Physiol Behav. 1999; 67: 533-537
        • Duman R.S.
        • Heninger G.R.
        • Nestler E.J.
        A molecular and cellular theory of depression.
        Arch Gen Psychiatry. 1997; 54: 597-606
        • Eisch A.J.
        • Barrot M.
        • Schad C.A.
        • Self D.W.
        • Nestler E.J.
        Opiates inhibit neurogenesis in the adult rat hippocampus.
        Proc Natl Acad Sci U S A. 2000; 97: 7579-7584
        • Ferguson S.M.
        • Brodkin J.D.
        • Lloyd G.K.
        • Menzaghi F.
        Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression.
        Psychopharmacology. 2000; 152: 295-303
        • Franklin K.B.J.
        • Paxinos G.
        The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego1997
        • Fryer J.D.
        • Lukas R.J.
        Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function.
        J Neurochem. 1999; 72: 1117-1124
        • Gentry C.L.
        • Lukas R.J.
        Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure.
        Curr Drug Target CNS Neurol Disord. 2002; 1: 359-385
      1. Harrist A, Beech RD, King SL, Zanardi A, Cleary MA, Caldarone BJ, et al (in press): Alteration of hippocampal cell proliferation in mice lacking the β2 subunit of the neuronal nicotinic acetylcholine receptor. Synapse.

        • Hennings E.C.
        • Kiss J.P.
        • Vizi E.S.
        Nicotinic acetylcholine receptor antagonist effect of fluoxetine in rat hippocampal slices.
        Brain Res. 1997; 759: 292-294
        • Janowsky D.S.
        • el-Yousef M.K.
        • Davis J.M.
        • Sekerke H.J.
        A cholinergic-adrenergic hypothesis of mania and depression.
        Lancet. 1972; 2: 632-635
        • Kenny P.J.
        • File S.E.
        • Neal M.J.
        Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release.
        J Neurochem. 2000; 75: 2409-2414
        • Laudenbach V.
        • Medja F.
        • Zoli M.
        • Rossi F.M.
        • Evrard P.
        • Changeux J.P.
        • et al.
        Selective activation of central subtypes of the nicotinic acetylcholine receptor has opposite effects on neonatal excitotoxic brain injuries.
        FASEB J. 2002; 16: 423-425
        • Lopez-Valdes H.E.
        • Garcia-Colunga J.
        Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake.
        Mol Psychiatry. 2001; 6: 511-519
        • Maier S.F.
        Learned helplessness and animal models of depression.
        Prog Neuropsychopharmacol Biol Psychiatry. 1984; 8: 435-446
        • Malberg J.E.
        • Duman R.S.
        Cell proliferation in adult hippocampus is decreased by inescapable stress.
        Neuropsychopharmacology. 2003; 28: 1562-1571
        • Malberg J.E.
        • Eisch A.J.
        • Nestler E.J.
        • Duman R.S.
        Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.
        J Neurosci. 2000; 20: 9104-9110
        • Mechawar N.
        • Saghatelyan A.
        • Grailhe R.
        • Scoriels L.
        • Gheusi G.
        • Gabellec M.M.
        • et al.
        Nicotinic receptors regulate the survival of newborn neurons in the adult olfactory bulb.
        Proc Natl Acad Sci U S A. 2004; 101: 9822-9826
        • Mihailescu D.S.
        • Palomero-Rivero M.
        • Meade-Huerta P.
        • Maza-Flores A.
        • Drucker-Colin R.
        Effects of nicotine and mecamylamine on rat dorsal raphe neurons.
        Eur J Pharmacol. 1998; 360: 31-36
        • Overstreet D.H.
        The Flinders sensitive line rats.
        Neurosci Biobehav Rev. 1993; 17: 51-68
        • Picciotto M.R.
        • Wickman K.
        Using knockout and transgenic mice to study neurophysiology and behavior.
        Physiol Rev. 1998; 78: 1131-1163
        • Picciotto M.R.
        • Zoli M.
        • Léna C.
        • Bessis A.
        • Lallemand Y.
        • Le Novere N.
        • et al.
        Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain.
        Nature. 1995; 374: 65-67
        • Popik P.
        • Kozela E.
        • Krawczyk M.
        Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram.
        Br J Pharmacol. 2003; 139: 1196-1202
        • Porsolt R.D.
        • Bertin A.
        • Jalfre M.
        Behavioral despair in mice.
        Arch Int Pharmacodyn Ther. 1977; 229: 327-336
        • Risch S.C.
        • Cohen R.M.
        • Janowsky D.S.
        • Kalin N.H.
        • Murphy D.L.
        Mood and behavioral effects of physostigmine on humans are accompanied by elevations in plasma beta-endorphin and cortisol.
        Science. 1980; 209: 1545-1546
        • Salin-Pascual R.J.
        • Rosas M.
        • Jimenez-Genchi A.
        • Rivera-Meza B.L.
        • Delgado-Parra V.
        Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression.
        J Clin Psychiatry. 1996; 57: 387-389
        • Santarelli L.
        • Saxe M.
        • Gross C.
        • Surget A.
        • Battaglia F.
        • Dulawa S.
        • et al.
        Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants.
        Science. 2003; 301: 805-809
        • Schofield G.G.
        • Witkop B.
        • Warnick J.E.
        • Albuquerque E.X.
        Differentiation of the open and closed states of the ionic channels of nicotinic acetylcholine receptors by tricyclic antidepressants.
        Proc Natl Acad Sci U S A. 1981; 78: 5240-5244
        • Semba J.
        • Mataki C.
        • Yamada S.
        • Nankai M.
        • Toru M.
        Antidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats.
        Biol Psychiatry. 1998; 43: 389-391
        • Shanks N.
        • Anisman H.
        Stressor-provoked behavioral changes in six strains of mice.
        Behav Neurosci. 1988; 102: 894-905
        • Shanks N.
        • Anisman H.
        Strain-specific effects of antidepressants on escape deficits induced by inescapable shock.
        Psychopharmacology. 1989; 99: 122-128
        • Sherman A.D.
        • Allers G.L.
        • Petty F.
        • Henn F.A.
        A neuropharmacologically-relevant animal model of depression.
        Neuropharmacology. 1979; 18: 891-893
        • Shytle R.D.
        • Silver A.A.
        • Lukas R.J.
        • Newman M.B.
        • Sheehan D.V.
        • Sanberg P.R.
        Nicotinic acetylcholine receptors as targets for antidepressants..
        Mol Psychiatry. 2002; 7: 525-535
        • Shytle R.D.
        • Silver A.A.
        • Sheehan K.H.
        • Sheehan D.V.
        • Sanberg P.R.
        Neuronal nicotinic receptor inhibition for treating mood disorders.
        Depress Anxiety. 2002; 16: 89-92
        • Slemmer J.E.
        • Martin B.R.
        • Damaj M.I.
        Bupropion is a nicotinic antagonist.
        J Pharmacol Exp Ther. 2000; 295: 321-327
        • Steru L.
        • Chermat R.
        • Thierry B.
        • Simon P.
        The tail suspension test.
        Psychopharmacology. 1985; 85: 367-370
        • Stevens T.R.
        • Krueger S.R.
        • Fitzsimonds R.M.
        • Picciotto M.R.
        Neuroprotection by nicotine in mouse primary cortical cultures involves activation of calcineurin and L-type calcium channel inactivation.
        J Neurosci. 2003; 23: 10093-10099
        • Tizabi Y.
        • Overstreet D.H.
        • Rezvani A.H.
        • Louis V.A.
        • Clark Jr, E.
        • Janowsky D.S.
        • Kling M.A.
        Antidepressant effects of nicotine in an animal model of depression.
        Psychopharmacology. 1999; 142: 193-199